Table 3.
Model 1 |
Model 2 |
Model 3 |
Model 4 |
|||||
---|---|---|---|---|---|---|---|---|
OR (95% CI) | p Value | OR (95% CI) | p Value | OR (95% CI) | p Value | OR (95% CI) | p Value | |
Aβ-40 | 1.39 (0.99–1.96) | 0.05 | 1.34 (0.95–1.89) | 0.09 | 1.47 (1.00–2.16) | 0.05 | 1.61 (1.03–2.53) | 0.03 |
Aβ-42 | 1.30 (0.93–1.83) | 0.13 | 1.27 (0.90–1.79) | 0.17 | 1.28 (0.90–1.83) | 0.17 | 1.34 (0.90–1.99) | 0.14 |
Aβ-42/Aβ-40 | 1.07 (0.78–1.49) | 0.66 | 1.07 (0.77–1.49) | 0.66 | 1.04 (0.75–1.45) | 0.80 | 1.06 (0.74–1.54) | 0.74 |
Model 1: unadjusted; Model 2: adjusted for age; Model 3: adjusted for age and cystatin C level; Model 4: adjusted for age, Modified Mini-Mental State Examination scores, cystatin C, APOE-4, and MRI identified infarcts. The odds ratios (ORs) were estimated with increments of 1 SD of plasma Aβ1-40 and Aβ1-42.